Pricing
  1. US-listed companies
  2. KYNTRA BIO, INC.
  3. Raw

KYNTRA BIO, INC.【KYNB】

Market cap
$28.19M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents1531746748912667817115611450
Short-term investments---5324078234266122-
Accounts receivable, net151086428421716130
Inventories----7173140423
Prepaid expenses and other current assets43551331020144232
Current assets held for sale---------111
Total current assets201267749690702755474493332197
Restricted time deposits7-----222-
Property and equipment, net1291241291274334282113-
Operating lease right-of-use assets------918068-
Other assets2253936541
Long-term assets held for sale---------17
Total assets471470899881857827774610424215
Accounts payable76696252631185
Accrued and other current liabilities----8412017322017362
Deferred revenue---140716131327
Operating Lease, Liability, Current------111014-
Current liabilities held for sale---------39
Total current liabilities67657789103163225274218133
Product development obligations15151717171918171817
Deferred revenue, net of current---13699138187186158115
Operating Lease, Liability, Noncurrent------898067-
Secured Long-Term Debt, Noncurrent--------7273
Liability Related To Sale Of Future Revenues Non Current-------495159
Other long-term liabilities56810644026631
Long-term liabilities held for sale---------0
Total liabilities274294316352322385545612586398
Redeemable non-controlling interests--------2121
Preferred Stock, Value, Issued----------
Common Stock, Value, Issued1111111111
Additional paid-in capital587--1,2261,3011,4001,4761,5411,6441,669
Accumulated other comprehensive loss-2-1-2-2-1-4-4-6-7-6
Accumulated deficit-408-470-596-716-785-974-1,264-1,558-1,842-1,889
Total stockholders' deficit attributable to FibroGen197175582528535441229-1-184-205
Nonredeemable Noncontrolling Interest--------2020
Non-controlling interests1919191919192020--
Total deficit197175582528535441229-1-184-205
Total liabilities, redeemable non-controlling interests and deficit471470899881857827774610424215